 Dong Wang
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebellar Neoplasms | 2 | 2022 | 130 | 0.870 |
Why?
| | Medulloblastoma | 2 | 2022 | 172 | 0.850 |
Why?
| | Desoxycorticosterone Acetate | 1 | 2017 | 3 | 0.590 |
Why?
| | Glucosides | 1 | 2018 | 36 | 0.580 |
Why?
| | Relaxin | 1 | 2017 | 15 | 0.580 |
Why?
| | Benzhydryl Compounds | 1 | 2018 | 60 | 0.570 |
Why?
| | Kidney Diseases | 2 | 2018 | 350 | 0.560 |
Why?
| | Bile Acids and Salts | 5 | 2020 | 171 | 0.510 |
Why?
| | Liver Diseases | 1 | 2018 | 255 | 0.490 |
Why?
| | Glioma | 4 | 2022 | 294 | 0.470 |
Why?
| | Acinar Cells | 5 | 2014 | 11 | 0.460 |
Why?
| | Kidney | 2 | 2017 | 1188 | 0.450 |
Why?
| | Heart | 1 | 2017 | 612 | 0.440 |
Why?
| | Myocardium | 1 | 2017 | 913 | 0.400 |
Why?
| | Zinc Fingers | 2 | 2009 | 43 | 0.380 |
Why?
| | Oryza | 2 | 2008 | 20 | 0.380 |
Why?
| | Genome, Plant | 2 | 2008 | 44 | 0.370 |
Why?
| | Pancreas | 4 | 2014 | 276 | 0.370 |
Why?
| | Arabidopsis | 2 | 2008 | 79 | 0.350 |
Why?
| | Hypertension | 1 | 2017 | 1056 | 0.330 |
Why?
| | Obesity | 2 | 2018 | 2508 | 0.310 |
Why?
| | Diet, Western | 2 | 2020 | 66 | 0.310 |
Why?
| | Biliary Atresia | 2 | 2021 | 185 | 0.290 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2017 | 192 | 0.260 |
Why?
| | Receptors, G-Protein-Coupled | 2 | 2017 | 194 | 0.250 |
Why?
| | Cell Line, Tumor | 5 | 2022 | 2711 | 0.240 |
Why?
| | Diabetic Nephropathies | 2 | 2017 | 234 | 0.230 |
Why?
| | Brain Stem Neoplasms | 2 | 2021 | 86 | 0.210 |
Why?
| | Ryanodine Receptor Calcium Release Channel | 2 | 2014 | 59 | 0.210 |
Why?
| | Liver | 3 | 2020 | 1637 | 0.210 |
Why?
| | Cell Proliferation | 4 | 2022 | 2187 | 0.200 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 41 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2022 | 56 | 0.190 |
Why?
| | Pancreatitis | 2 | 2012 | 107 | 0.190 |
Why?
| | Radiation Tolerance | 1 | 2022 | 92 | 0.190 |
Why?
| | Receptor, trkC | 1 | 2021 | 10 | 0.190 |
Why?
| | Bile Ducts, Extrahepatic | 1 | 2021 | 24 | 0.190 |
Why?
| | Receptor, trkB | 1 | 2021 | 28 | 0.180 |
Why?
| | Rhabdoid Tumor | 1 | 2022 | 80 | 0.180 |
Why?
| | Jumonji Domain-Containing Histone Demethylases | 1 | 2021 | 59 | 0.180 |
Why?
| | Quinazolines | 1 | 2022 | 240 | 0.180 |
Why?
| | Polycomb Repressive Complex 1 | 1 | 2020 | 40 | 0.170 |
Why?
| | Sevelamer | 1 | 2020 | 9 | 0.170 |
Why?
| | Transcriptional Elongation Factors | 1 | 2020 | 32 | 0.170 |
Why?
| | Immunoglobulin M | 1 | 2021 | 246 | 0.170 |
Why?
| | Piperazines | 1 | 2022 | 309 | 0.170 |
Why?
| | DNA Repair | 1 | 2021 | 184 | 0.170 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2017 | 160 | 0.160 |
Why?
| | Animals | 14 | 2022 | 31709 | 0.160 |
Why?
| | Aging | 2 | 2020 | 1618 | 0.160 |
Why?
| | Pyrazoles | 1 | 2022 | 362 | 0.160 |
Why?
| | Apoptosis | 3 | 2022 | 2363 | 0.160 |
Why?
| | Taurolithocholic Acid | 3 | 2014 | 3 | 0.160 |
Why?
| | Membrane Glycoproteins | 1 | 2021 | 430 | 0.160 |
Why?
| | Histones | 2 | 2020 | 535 | 0.150 |
Why?
| | Proto-Oncogene Proteins | 1 | 2022 | 608 | 0.150 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2022 | 445 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2022 | 551 | 0.150 |
Why?
| | Plant Proteins | 2 | 2009 | 81 | 0.150 |
Why?
| | Bile Ducts | 1 | 2018 | 68 | 0.150 |
Why?
| | Mice, Obese | 1 | 2018 | 53 | 0.150 |
Why?
| | Lipid Metabolism | 2 | 2020 | 444 | 0.150 |
Why?
| | Heart Function Tests | 1 | 2017 | 58 | 0.140 |
Why?
| | Urinalysis | 1 | 2017 | 64 | 0.140 |
Why?
| | Kidney Glomerulus | 1 | 2018 | 100 | 0.140 |
Why?
| | Kidney Function Tests | 1 | 2017 | 140 | 0.140 |
Why?
| | Kidney Tubules | 1 | 2017 | 107 | 0.140 |
Why?
| | Mice, Inbred C57BL | 4 | 2020 | 4694 | 0.140 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 245 | 0.140 |
Why?
| | Calcium Signaling | 3 | 2013 | 217 | 0.130 |
Why?
| | Liver Cirrhosis | 1 | 2018 | 227 | 0.130 |
Why?
| | Mice | 11 | 2022 | 14872 | 0.120 |
Why?
| | Renal Insufficiency | 1 | 2017 | 137 | 0.120 |
Why?
| | Oxidative Stress | 2 | 2018 | 1076 | 0.120 |
Why?
| | Antineoplastic Agents | 2 | 2022 | 1879 | 0.120 |
Why?
| | Weight Gain | 1 | 2018 | 453 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 299 | 0.120 |
Why?
| | Electrocardiography | 1 | 2017 | 560 | 0.120 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1230 | 0.110 |
Why?
| | Genes, Plant | 3 | 2009 | 43 | 0.110 |
Why?
| | Lipids | 1 | 2018 | 580 | 0.110 |
Why?
| | Mutation | 2 | 2021 | 3346 | 0.110 |
Why?
| | Autoantibodies | 1 | 2021 | 1346 | 0.110 |
Why?
| | Cytological Techniques | 1 | 2013 | 23 | 0.110 |
Why?
| | Adenoviridae Infections | 1 | 2013 | 15 | 0.110 |
Why?
| | B-Lymphocytes | 1 | 2018 | 766 | 0.110 |
Why?
| | Inositol 1,4,5-Trisphosphate Receptors | 1 | 2012 | 26 | 0.100 |
Why?
| | Secretory Vesicles | 1 | 2012 | 24 | 0.100 |
Why?
| | Cytosol | 1 | 2012 | 208 | 0.100 |
Why?
| | Calcineurin | 1 | 2012 | 89 | 0.100 |
Why?
| | Blood Pressure | 1 | 2017 | 1538 | 0.090 |
Why?
| | Cytokines | 1 | 2018 | 1841 | 0.090 |
Why?
| | Inflammation | 2 | 2018 | 2480 | 0.090 |
Why?
| | Child | 4 | 2022 | 18420 | 0.090 |
Why?
| | Calcium | 2 | 2014 | 1108 | 0.090 |
Why?
| | Insulin Resistance | 1 | 2018 | 1072 | 0.080 |
Why?
| | Epigenomics | 2 | 2020 | 101 | 0.080 |
Why?
| | Gossypium | 1 | 2009 | 2 | 0.080 |
Why?
| | Rats | 1 | 2017 | 4958 | 0.080 |
Why?
| | Blood Glucose | 1 | 2018 | 1828 | 0.080 |
Why?
| | Kruppel-Like Transcription Factors | 1 | 2009 | 61 | 0.080 |
Why?
| | Humans | 13 | 2022 | 114705 | 0.080 |
Why?
| | Phosphoprotein Phosphatases | 1 | 2008 | 64 | 0.080 |
Why?
| | Male | 9 | 2021 | 55607 | 0.080 |
Why?
| | Chromosomes, Plant | 1 | 2008 | 8 | 0.080 |
Why?
| | RNA, Plant | 1 | 2008 | 9 | 0.080 |
Why?
| | Gene Duplication | 1 | 2008 | 62 | 0.070 |
Why?
| | Phylogeny | 2 | 2008 | 789 | 0.070 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 2 | 2021 | 797 | 0.070 |
Why?
| | Amino Acid Motifs | 1 | 2008 | 197 | 0.070 |
Why?
| | Biomarkers | 1 | 2017 | 3408 | 0.070 |
Why?
| | Arabidopsis Proteins | 1 | 2008 | 65 | 0.070 |
Why?
| | Sequence Alignment | 1 | 2008 | 323 | 0.070 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2008 | 353 | 0.070 |
Why?
| | Multigene Family | 1 | 2008 | 190 | 0.070 |
Why?
| | Cholesterol | 2 | 2020 | 367 | 0.070 |
Why?
| | Podocytes | 2 | 2017 | 44 | 0.070 |
Why?
| | Chromatin | 2 | 2020 | 428 | 0.070 |
Why?
| | Child, Preschool | 4 | 2021 | 9118 | 0.070 |
Why?
| | DNA Primers | 1 | 2008 | 510 | 0.070 |
Why?
| | Signal Transduction | 2 | 2017 | 4516 | 0.070 |
Why?
| | Species Specificity | 1 | 2008 | 542 | 0.070 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2022 | 859 | 0.070 |
Why?
| | Stress, Physiological | 1 | 2009 | 378 | 0.060 |
Why?
| | Carrier Proteins | 1 | 2009 | 695 | 0.060 |
Why?
| | RNA, Messenger | 3 | 2017 | 2553 | 0.060 |
Why?
| | RNA-Binding Proteins | 1 | 2008 | 345 | 0.060 |
Why?
| | Base Sequence | 1 | 2008 | 2114 | 0.060 |
Why?
| | Evolution, Molecular | 1 | 2008 | 430 | 0.060 |
Why?
| | Gene Expression | 1 | 2009 | 1421 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2008 | 1982 | 0.060 |
Why?
| | Software | 1 | 2008 | 530 | 0.060 |
Why?
| | Ryanodine | 2 | 2014 | 13 | 0.050 |
Why?
| | L-Lactate Dehydrogenase | 2 | 2014 | 107 | 0.050 |
Why?
| | Molecular Sequence Data | 1 | 2008 | 2785 | 0.050 |
Why?
| | Disease Progression | 2 | 2021 | 2380 | 0.050 |
Why?
| | Protein Isoforms | 2 | 2014 | 338 | 0.050 |
Why?
| | Gene Expression Profiling | 1 | 2008 | 1518 | 0.050 |
Why?
| | Radiation, Ionizing | 1 | 2022 | 72 | 0.050 |
Why?
| | Mitochondria | 2 | 2017 | 747 | 0.050 |
Why?
| | Portoenterostomy, Hepatic | 1 | 2021 | 53 | 0.050 |
Why?
| | Teratoma | 1 | 2022 | 92 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2022 | 213 | 0.050 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 1 | 2022 | 172 | 0.050 |
Why?
| | Algorithms | 1 | 2008 | 1470 | 0.050 |
Why?
| | Fluorescent Antibody Technique | 1 | 2021 | 397 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2021 | 284 | 0.040 |
Why?
| | Lactobacillus | 1 | 2020 | 24 | 0.040 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 117 | 0.040 |
Why?
| | Cecum | 1 | 2020 | 32 | 0.040 |
Why?
| | Astrocytoma | 1 | 2020 | 108 | 0.040 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3535 | 0.040 |
Why?
| | Chemokine CCL2 | 1 | 2020 | 105 | 0.040 |
Why?
| | Reactive Oxygen Species | 1 | 2022 | 531 | 0.040 |
Why?
| | Collagen Type I | 1 | 2020 | 108 | 0.040 |
Why?
| | Sulfonamides | 1 | 2022 | 445 | 0.040 |
Why?
| | Gene Expression Regulation, Plant | 2 | 2009 | 48 | 0.040 |
Why?
| | Lysine | 1 | 2020 | 242 | 0.040 |
Why?
| | Cholic Acids | 1 | 2017 | 17 | 0.040 |
Why?
| | Chenodeoxycholic Acid | 1 | 2017 | 12 | 0.040 |
Why?
| | Glomerular Mesangium | 1 | 2017 | 17 | 0.040 |
Why?
| | Feces | 1 | 2020 | 373 | 0.040 |
Why?
| | Mitochondrial Turnover | 1 | 2017 | 4 | 0.040 |
Why?
| | Mice, Inbred DBA | 1 | 2017 | 174 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2020 | 448 | 0.040 |
Why?
| | Sodium-Glucose Transporter 2 | 1 | 2017 | 17 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2017 | 91 | 0.030 |
Why?
| | Adaptive Immunity | 1 | 2018 | 155 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2017 | 271 | 0.030 |
Why?
| | Albuminuria | 1 | 2017 | 164 | 0.030 |
Why?
| | Hypolipidemic Agents | 1 | 2017 | 86 | 0.030 |
Why?
| | Spleen | 1 | 2018 | 487 | 0.030 |
Why?
| | Caloric Restriction | 1 | 2017 | 90 | 0.030 |
Why?
| | Longevity | 1 | 2017 | 137 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 778 | 0.030 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 386 | 0.030 |
Why?
| | Cell Culture Techniques | 1 | 2018 | 343 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2020 | 521 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2018 | 1144 | 0.030 |
Why?
| | Cell Line | 1 | 2021 | 2637 | 0.030 |
Why?
| | Triglycerides | 1 | 2017 | 467 | 0.030 |
Why?
| | Fibrosis | 1 | 2017 | 453 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2020 | 1143 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1083 | 0.030 |
Why?
| | Carbachol | 1 | 2014 | 21 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2017 | 477 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2018 | 1629 | 0.030 |
Why?
| | Gastrointestinal Microbiome | 1 | 2020 | 501 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2020 | 1701 | 0.030 |
Why?
| | Ceruletide | 1 | 2012 | 4 | 0.030 |
Why?
| | Amylases | 1 | 2012 | 13 | 0.030 |
Why?
| | Egtazic Acid | 1 | 2012 | 44 | 0.030 |
Why?
| | Chymotrypsin | 1 | 2012 | 16 | 0.030 |
Why?
| | Cell Death | 1 | 2014 | 323 | 0.030 |
Why?
| | Adenoviridae | 1 | 2013 | 184 | 0.030 |
Why?
| | Dantrolene | 1 | 2012 | 5 | 0.030 |
Why?
| | Severity of Illness Index | 1 | 2020 | 2540 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4100 | 0.030 |
Why?
| | NFATC Transcription Factors | 1 | 2012 | 78 | 0.030 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 801 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2020 | 979 | 0.020 |
Why?
| | Cell Polarity | 1 | 2012 | 131 | 0.020 |
Why?
| | Tacrolimus | 1 | 2012 | 134 | 0.020 |
Why?
| | Female | 3 | 2021 | 59521 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 3886 | 0.020 |
Why?
| | Salicylic Acid | 1 | 2009 | 8 | 0.020 |
Why?
| | Plants, Genetically Modified | 1 | 2009 | 18 | 0.020 |
Why?
| | Plant Diseases | 1 | 2009 | 32 | 0.020 |
Why?
| | Droughts | 1 | 2009 | 26 | 0.020 |
Why?
| | Dehydration | 1 | 2009 | 40 | 0.020 |
Why?
| | Protein Phosphatase 2C | 1 | 2008 | 14 | 0.020 |
Why?
| | Gene Library | 1 | 2009 | 114 | 0.020 |
Why?
| | NF-kappa B | 1 | 2012 | 641 | 0.020 |
Why?
| | Brain | 1 | 2020 | 2371 | 0.020 |
Why?
| | Infant | 1 | 2021 | 7964 | 0.020 |
Why?
| | Cell Nucleus | 1 | 2009 | 554 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2017 | 2096 | 0.010 |
Why?
| | Time Factors | 1 | 2012 | 6116 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 17853 | 0.010 |
Why?
|
|
Wang's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|